Stay updated on Gantenerumab in Mild Alzheimer Disease Clinical Trial
Sign up to get notified when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.

Latest updates to the Gantenerumab in Mild Alzheimer Disease Clinical Trial page
- Check7 days agoChange DetectedThe page now shows Revision: v3.6.4, replacing the previous v3.6.3. It reflects a minor internal update without altering the study details presented on the page.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision label updated from v3.6.2 to v3.6.3 to reflect a newer site version.SummaryDifference0.0%

- Check36 days agoChange DetectedAdded a new 2024 publication citation for Long-Term Safety of Gantenerumab in Alzheimer’s disease to the study's Publications list, listing authors Neve A et al. with the DOI; the revision tag was updated to v3.6.2.SummaryDifference0.0%

- Check50 days agoChange DetectedRecruitment status has been updated to closed, and new user guidance sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The removal of the old 'Intervention / Treatment' heading and the update to the site revision banner (v3.6.0) reflect a reorganization and version update.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page’s revision label was updated from v3.5.4 to v3.5.5, indicating a newer page build. This reflects an update to the page’s versioning rather than changes to the study content.SummaryDifference0.0%

- Check79 days agoChange DetectedThe page's revision label was updated from v3.5.3 to v3.5.4, indicating a minor update to the site; the study details and navigation remain unchanged.SummaryDifference0.0%

Stay in the know with updates to Gantenerumab in Mild Alzheimer Disease Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gantenerumab in Mild Alzheimer Disease Clinical Trial page.